Bangladesh relies solely on Serum, COVAX | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Wednesday
September 27, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
WEDNESDAY, SEPTEMBER 27, 2023
Bangladesh relies solely on Serum, COVAX

Covid-19 in Bangladesh

Tawsia Tajmim
07 January, 2021, 10:30 pm
Last modified: 07 January, 2021, 10:31 pm

Related News

  • Beximco Green Sukuk: A fixed income opportunity overlooked
  • Beximco completes two projects financed by Sukuk fund
  • Two Beximco firms' profits drop in March quarter
  • Man arrested for alleged fraud involving Beximco's Tk46cr meant for solar schemes
  • Costly raw materials slash two Beximco firms’ profits

Bangladesh relies solely on Serum, COVAX

Meanwhile, Beximco Pharmaceuticals Ltd said it will bring in the doses of Oxford vaccine in time as per the agreement with the Serum Institute

Tawsia Tajmim
07 January, 2021, 10:30 pm
Last modified: 07 January, 2021, 10:31 pm
Small bottles labelled with "Vaccine" stickers stand near a medical syringe in front of displayed "Coronavirus COVID-19" words in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
Small bottles labelled with "Vaccine" stickers stand near a medical syringe in front of displayed "Coronavirus COVID-19" words in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

Although the availability of the Oxford vaccine seems to have become uncertain, Bangladesh still depends on the Oxford-AstraZeneca vaccine manufactured by the Serum Institute of India and COVAX vaccines to fight against the novel coronavirus.

The Directorate General of Health Services (DGHS) expressed hope that Bangladesh would not suffer because of the uncertainty regarding the Oxford vaccine. The government has continued its preparations for the Covid immunisation programme, centring on the Oxford vaccine, it said.

Meanwhile, Beximco Pharmaceuticals Ltd said it will bring in the doses of Oxford vaccine in time as per the agreement with the Serum Institute.

Professor Meerjady Sabrina Flora, additional director general of the DGHS, said, "We have not made any agreement with any company for vaccines, other than Oxford vaccine, but talks are on with everyone."

The government had initial talks for Russia's Sputnik-5 vaccine and another Chinese vaccine.

COVAX vaccines coordinated by GAVI, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations and the WHO will cover 20 percent of the country's population.  The vaccines will be available in phases. Doses of the first lot are expected to arrive by June this year, Flora said.

COVAX is an international health group that made deals with vaccine manufacturers to ensure that low and middle-income countries get equal access to coronavirus vaccines.

Flora, also chair of the National Deployment and Vaccination Plan for Covid-19 vaccines, said the preparation for vaccination was on. "Now we are training health workers."

On 5 November last year, the health ministry signed a tripartite memorandum of understanding with the Serum Institute and Beximco to import the vaccine developed by Oxford-AstraZeneca.

About three crore doses have been secured, which Serum would deliver over a period of six months – 50 lakh a month. The doses will be given to 1.5 crore people -- 9% of the population.  

Bangladesh has paid nearly Tk 510 crore in advance to the Serum Institute for the doses.

But the recent statement of the chief executive officer of the Serum Institute over a ban on vaccine export led to concerns about the availability of the vaccine.

The Indian government later said there was no restriction on vaccine export.

Experts think that the government should look for alternative sources now.

Prof Muzaherul Huq, former adviser of the World Health Organisation's Southeast Asia region, said most of the countries already had more than one source to get Covid vaccines.

Given the current situation, Bangladesh should immediately tap into other sources, and the best choices would be China or Indonesia, he added.

Noted virologist Professor Nazrul Islam said the government should have made deals with multiple sources for vaccine.

"We would have had an alternative had we allowed the trial of Chinese Sinovac vaccine. Without wasting any time further, we should search for other sources."

Rabbur Reza, Beximco Pharma's chief operating officer, said, "We have not yet received the approval of the regulatory authority [for vaccine import]. We just got the NOC to bring the vaccine. An expert committee meeting was held on Thursday. We will bring the vaccine within a month after they check all the documents and give the go-ahead.

"We still believe we can get the vaccine at the right time," Reza said.

Coronavirus chronicle / Top News

Coronavirus Vaccine / COVAX / Serum Institute of India (SII) / AstraZeneca Covid-19 Vaccine / Oxford Covid-19 Vaccine / Beximco

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Power price, subsidy to rise as govt has to pay producers at latest dollar rate
    Power price, subsidy to rise as govt has to pay producers at latest dollar rate
  • (From the left) Zahid Hussain, Ahsan H Mansur and Samir Sattar. Illustration: TBS
    What impact will a forward forex rate have?
  • Photo: BSS
    BB formulates digital payment policies with quick refund, penalty provisions

MOST VIEWED

  • US dollar banknotes are seen in this illustration taken on 10 March 2023. Photo: Reuters
    Taka weakens even further
  • The Fitch Ratings logo is seen at their offices at Canary Wharf financial district in London,Britain, March 3, 2016. REUTERS/Reinhard Krause
    Fitch now rates Bangladesh's foreign debt outlook negative
  • Experts say Dhaka has at least 18 times more than the population it can actually support. Photo: Rajib Dhar
    DAP relaxes floor area ratio, planners raise concerns over Dhaka's livability
  • Dollar rates raised to Tk110 for remitters, exporters
    Dollar rates raised to Tk110 for remitters, exporters
  • Why Biman struggles to overcome pilot shortage
    Why Biman struggles to overcome pilot shortage
  • Record Bangladeshis hired in Italy this year, $800m sent home
    Record Bangladeshis hired in Italy this year, $800m sent home

Related News

  • Beximco Green Sukuk: A fixed income opportunity overlooked
  • Beximco completes two projects financed by Sukuk fund
  • Two Beximco firms' profits drop in March quarter
  • Man arrested for alleged fraud involving Beximco's Tk46cr meant for solar schemes
  • Costly raw materials slash two Beximco firms’ profits

Features

(From the left) Zahid Hussain, Ahsan H Mansur and Samir Sattar. Illustration: TBS

What impact will a forward forex rate have?

20m | Panorama
India-Canada clash should be a wakeup call

India-Canada clash should be a wakeup call

23h | Panorama
It is highly unlikely that inflation rate is going to come down soon. PHOTO: TBS

No more central bank loans to the govt: Will it be enough to curb inflation?

23h | Panorama
Why Bangladeshi patients flock to India

Why Bangladeshi patients flock to India

1d | Panorama

More Videos from TBS

How dependent is Canada's economy on India?

How dependent is Canada's economy on India?

13h | TBS World
IMEC; Is the main objective to stop China?

IMEC; Is the main objective to stop China?

12h | TBS World
Why Biman struggles to overcome pilot shortage

Why Biman struggles to overcome pilot shortage

15h | TBS Insight
Global Finance's report card: Bangladesh Bank governor got ‘D’

Global Finance's report card: Bangladesh Bank governor got ‘D’

15h | TBS Stories
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]